A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of RXC007.

Phase 1

Redx Pharma Plc

Simbec Research